Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders

[1]  R. Spanagel,et al.  Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats , 2014, European Neuropsychopharmacology.

[2]  Yiyun Huang,et al.  Elevated Brain Cannabinoid CB1 Receptor Availability in Posttraumatic Stress Disorder: A Positron Emission Tomography Study , 2013, Molecular Psychiatry.

[3]  B. Roozendaal,et al.  Plasma Concentrations of Endocannabinoids and Related Primary Fatty Acid Amides in Patients with Post-Traumatic Stress Disorder , 2013, PloS one.

[4]  M. Hellmich,et al.  Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia , 2012, Translational Psychiatry.

[5]  F. Krueger,et al.  Fatty-acid amide hydrolase polymorphisms and post-traumatic stress disorder after penetrating brain injury , 2012, Translational Psychiatry.

[6]  B. Alger,et al.  Supply and demand for endocannabinoids , 2011, Trends in Neurosciences.

[7]  D. Piomelli,et al.  Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure. , 2011, The Journal of clinical endocrinology and metabolism.

[8]  Paul E Mullen,et al.  Psychopathology in a large cohort of sexually abused children followed up to 43 years. , 2010, Child abuse & neglect.

[9]  P. Falkai,et al.  Borderline personality disorder: a dysregulation of the endogenous opioid system? , 2010, Psychological review.

[10]  R. Kessler,et al.  Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. , 2010, Archives of general psychiatry.

[11]  I. Galve-Roperh,et al.  The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[12]  K. Taber,et al.  Endocannabinoids: Stress, Anxiety, and Fear , 2009 .

[13]  B. Lutz.  The Endocannabinoid System and Extinction Learning , 2007, Molecular Neurobiology.

[14]  Joachim Klosterkötter,et al.  Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms , 2004, Neuropsychopharmacology.

[15]  S. Gaetani,et al.  Modulation of anxiety through blockade of anandamide hydrolysis , 2003, Nature Medicine.

[16]  W. Zieglgänsberger,et al.  The endogenous cannabinoid system controls extinction of aversive memories , 2002, Nature.